Polyrizon’s innovative hydrogel-based nasal spray, Nasarix Allergy Blocker (PL-14), is on the cusp of its first human...
In the heart of San Francisco, a city defined by its history of radical social movements and...
As the 2026 school year begins across the United States, a quiet but profound public health crisis...
The pharmaceutical landscape is currently undergoing a seismic shift. As clinical pipelines expand in complexity and the...
The landscape of cosmetic plastic surgery in the United States is undergoing a profound and rapid transformation....
In a significant milestone for neurological care, Empatica, a leader in wearable health monitoring, has officially received...
Igniting Hope and Driving Progress: Empowering Fundraisers for the National Breast Cancer Foundation
Igniting Hope and Driving Progress: Empowering Fundraisers for the National Breast Cancer Foundation
August 20, 2025 – In the ongoing fight against breast cancer, fundraising extends far beyond the mere...
August 25, 2025 — In the quiet moments of a Monday morning in September 2024, the trajectory...
In the complex landscape of mental health, clinicians and researchers have long grappled with a fundamental, age-old...
Adaptin Bio’s innovative therapy, APTN-101, utilizing its proprietary BRiTE platform, has commenced its first-in-human Phase I clinical...
